Genflow Biosciences
GENF.LPre-clinicalWe are a London-based biotech company that specialises in anti ageing treatments and longevity research. Discover more on our human life extension research.
Market Cap
$10.6M
+36.2% period
Pipeline
—
Patents
—
Publications
—
GENF.L · Stock Price
USD 1.98+0.52 (+36.21%)
Historical price data
About
We are a London-based biotech company that specialises in anti ageing treatments and longevity research. Discover more on our human life extension research.
RNA & Gene Therapy
Funding History
1Total raised:$6.5M
IPO$6.5MFeb 15, 2022